http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104968648-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
filingDate 2013-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50e070c301ef7469dbb2b78b2681f878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba708c3e9ff15f030e0007dff0f266f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4030dfb6b6582b7f4541b4400cf10079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8e2c0f4ece34f59d4308c61aa3bdad3
publicationDate 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104968648-A
titleOfInvention Prodrugs of 1,4-benzodiazepine compounds
abstract The invention discloses compounds of formula (I) and salts thereof, wherein: a) R 1 is H or -CH 3 and R 2 is R y ; or b) R 1 is R x and R 2 is H; wherein R x and Ry is as disclosed in this application. The invention also discloses the method of using these compounds to inhibit Notch receptors, and the pharmaceutical composition containing these compounds. These compounds are prodrugs of compounds that are useful in the treatment, prevention or slowing of the progression of diseases or disorders such as cancer in various fields of medicine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142629-B
priorityDate 2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069293-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421379604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163648721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88932950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15299283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467970997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465489233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420689442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10600827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407004254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465281454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424651680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68315009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466451538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163792907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421574849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466463585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466109275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90090823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466463586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433065601

Total number of triples: 53.